Managing injectable drugs in children treated for MDR-TB скачать в хорошем качестве

Managing injectable drugs in children treated for MDR-TB

This webinar, recorded on April 29, 2015 and organized in partnership with the Sentinel Project, covers the following topics: Rreview the use of second-line injectables for children with MDR-TB, including current international recommendations, choice of drug, duration of treatment, and adverse effects; Discuss safe and age-appropriate intramuscular injection in children; Review key aspects of age-appropriate audiology assessment in children treated with second-line injectables, and discuss how to respond to ototoxicity; Highlight future approaches to limiting the adverse effects associated with second-line injectables in children. Presented by Dr. Tony Garcia-Prats, Ms. Ann Raftery and Ms. Kayleen Jacobs. The Sentinel Project on Pediatric Drug-Resistant Tuberculosis is a global partnership of researchers, caregivers, and advocates who share a vision of a world where no child dies from this curable disease. Members collaborate to raise the visibility of this vulnerable population of children, and to share evidence and resources that can increase children’s access to prompt and effective treatment. For more information and to join this network, please visit www.sentinel-project.org